<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="137976">
  <!-- This xml conforms to an XML Schema at:
    http://clinicaltrials.gov/ct2/html/images/info/public.xsd
 and an XML DTD at:
    http://clinicaltrials.gov/ct2/html/images/info/public.dtd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on June 04, 2014</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>http://clinicaltrials.gov/show/NCT02028481</url>
  </required_header>
  <id_info>
    <org_study_id>2012815b1</org_study_id>
    <nct_id>NCT02028481</nct_id>
  </id_info>
  <brief_title>Air Tamponade in Macular Holes &lt; 400 μm</brief_title>
  <official_title>Air Tamponade in Macular Holes &lt; 400 μm</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Helse Stavanger HF</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Haukeland University Hospital</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Helse Stavanger HF</source>
  <oversight_info>
    <authority>Norway: Ethics Committee</authority>
    <authority>Norway: Data Protection Authority</authority>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Macular hole is a hole formation which takes place in the center of the retina. Such a hole
      needs surgical steps in order to close. Closure of the macular hole will lead to a
      substantially improvement of vision in most cases. Following macular hole surgery a
      tamponade of intraocular gas is normally injected in order to keep the macula dry for the
      postoperative period. Postoperative face down position for a week was earlier standard.
      Several authors report of good closure rates with both air tamponade or lack of face down
      positioning. In this study standard pars plana vitrectomy with peeling of the internal
      limiting membrane (ILM) will be performed. The gas tamponade will be replaced by air.
      Postoperative face down positioning will not be used. Only macular holes less than 400 μm
      will be included.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date>December 2013</start_date>
  <completion_date type="Anticipated">December 2014</completion_date>
  <primary_completion_date type="Anticipated">December 2014</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <study_design>Endpoint Classification: Safety/Efficacy Study, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Treatment</study_design>
  <primary_outcome>
    <measure>Closure rate of macular hole</measure>
    <time_frame>1 month after enrollment</time_frame>
    <safety_issue>No</safety_issue>
  </primary_outcome>
  <other_outcome>
    <measure>Visual gain after 6 months of follow up</measure>
    <time_frame>6 months after enrollment</time_frame>
    <safety_issue>No</safety_issue>
  </other_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Anticipated">13</enrollment>
  <condition>Macular Hole Less Than 400 μm in Diameter</condition>
  <arm_group>
    <arm_group_label>Postoperative air tamponade</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Pars plana vitrectomy, ILM peeling and air tamponade. No postoperative face down positioning. All patients need to be pseudophakic prior to intervention.</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Postoperative air tamponade</intervention_name>
    <description>Pars plana vitrectomy, ILM peeling and air tamponade. No postoperative face down positioning. All patients need to be pseudophakic prior to intervention.</description>
    <arm_group_label>Postoperative air tamponade</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Primary macular hole less than 400 μm in diameter

          -  Duration of symptoms less than 36 months

          -  Informed consent

        Exclusion Criteria:

          -  Previous vitreomacular surgery

          -  Myopia more than 6 diopters

          -  Ocular trauma

          -  Disease affecting visual function
      </textblock>
    </criteria>
    <gender>Both</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Vegard Forsaa, MD</last_name>
    <role>Study Director</role>
    <affiliation>Helse Stavanger HF</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Vegard Forsaa, MD</last_name>
    <phone>+47 4790239747</phone>
    <email>vegard.forsaa@sus.no</email>
  </overall_contact>
  <location>
    <facility>
      <name>Stavanger University Hospital, Department of Ophthalmology</name>
      <address>
        <city>Stavanger</city>
        <zip>4016</zip>
        <country>Norway</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Vegard Forsaa, MD</last_name>
      <phone>+47 48152212</phone>
      <email>vegard.forsaa@sus.no</email>
    </contact>
    <investigator>
      <last_name>Vegard Forsaa, MDD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Norway</country>
  </location_countries>
  <verification_date>January 2014</verification_date>
  <lastchanged_date>January 3, 2014</lastchanged_date>
  <firstreceived_date>January 3, 2014</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Macular hole</keyword>
  <keyword>Vitreoretinal surgery</keyword>
  <keyword>Macular surgery</keyword>
  <keyword>Air tamponade</keyword>
  <is_fda_regulated>No</is_fda_regulated>
  <has_expanded_access>No</has_expanded_access>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Retinal Perforations</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
